Screening compound: C26H35N5O4 (L631-0228)

Screening compound: C<sub>26</sub>H<sub>35</sub>N<sub>5</sub>O<sub>4</sub> (L631-0228)
Screening compound: C<sub>26</sub>H<sub>35</sub>N<sub>5</sub>O<sub>4</sub> (L631-0228) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C26H35N5O4 (L631-0228)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L631-0228

Molecular Formula

C26H35N5O4 (C26 H35 N5 O4)

Compound Name

N-[(2-methoxyphenyl)methyl]-1-[1-methyl-5-(2-methylpropanoyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carbonyl]piperidine-4-carboxamide

IUPAC name

N-[(2-methoxyphenyl)methyl]-1-[1-methyl-5-(2-methylpropanoyl)-1H4H5H6H7H-pyrazolo[43-c]pyridine-3-carbonyl]piperidine-4-carboxamide

SMILES

CC(C)C(N(CC1)Cc2c1n(C)nc2C(N(CC1)CCC1C(NCc(cccc1)c1OC)=O)=O)=O

InChI

InChI=1S/C26H35N5O4/c1-17(2)25(33)31-14-11-21-20(16-31)23(28-29(21)3)26(34)30-12-9-18(10-13-30)24(32)27-15-19-7-5-6-8-22(19)35-4/h5-8,17-18H,9-16H2,1-4H3,(H,27,32)

InChI Key

BGYAYIQTDMEWIJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27642945

C26H35N5O4 (L631-0228) in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

MCL1 Targeted Library (12200 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Proteases
  • Kinases
  • GPCR
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with C26H35N5O4 (L631-0228) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C26H35N5O4 (L631-0228)?
Check Price and Availability of C26H35N5O4 (L631-0228), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C26H35N5O4 (L631-0228) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C26H35N5O4 (L631-0228)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C26H35N5O4 (L631-0228)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C26H35N5O4 (L631-0228) available by request